Details

Autor(en) / Beteiligte

• Ziats, Mark N.
• Goin-Kochel, Robin P.
• Berry, Leandra N.
• Ali, May
• Ge, Jun
• Guffey, Danielle
• Rosenfeld, Jill A.
• Bader, Patricia
• Gambello, Michael J.
• Wolf, Varina
• Penney, Lynette S.
• Miller, Ryan
• Lebel, Robert Roger
• Kane, Jeffrey
• Bachman, Kristine
• Troxell, Robin
• Clark, Gary
• Minard, Charles G.
• Stankiewicz, Pawel
• Beaudet, Arthur
• Schaaf, Christian P.

Titel

The complex behavioral phenotype of 15q13.3 microdeletion syndrome

Ist Teil von

• Genetics in medicine, 2016-11, Vol.18 (11), p.1111-1118

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2016

Quelle

MEDLINE

Beschreibungen/Notizen

• Chromosome 15q13.3 represents a hotspot for genomic rearrangements due to repetitive sequences mediating nonallelic homologous recombination. Deletions of 15q13.3 have been identified in the context of multiple neurological and psychiatric disorders, but a prospective clinical and behavioral assessment of affected individuals has not yet been reported. Eighteen subjects with 15q13.3 microdeletion underwent a series of behavioral assessments, along with clinical history and physical examination, to comprehensively define their behavioral phenotypes. Cognitive deficits are the most prevalent feature in 15q13.3 deletion syndrome, with an average nonverbal IQ of 60 among the patients studied. Autism spectrum disorder was highly penetrant, with 31% of patients meeting clinical criteria and exceeding cutoff scores on both ADOS-2 and ADI-R. Affected individuals exhibited a complex pattern of behavioral abnormalities, most notably hyperactivity, attention problems, withdrawal, and externalizing symptoms, as well as impairments in functional communication, leadership, adaptive skills, and activities of daily living. The 15q13.3 deletion syndrome encompasses a heterogeneous behavioral phenotype that poses a major challenge to parents, caregivers, and treating providers. Further work to more clearly delineate genotype–phenotype relationships in 15q13.3 deletions will be important for anticipatory guidance and development of targeted therapies. Genet Med18 11, 1111–1118.